You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.
You are now leaving ironwoodpharma.com.

Our Research & Development

Ironwood invests to bring important medicines to patients through the
development of innovative products in areas of high unmet need.

Our U.S. pipeline:
Status of Selected Key Development Programs as of February 22, 2018.
Represents ongoing phase of development; does not correspond to initiation or completion of a particular phase.

* Click here for LINZESS full US Prescribing Information including BOXED WARNING »
** Click here for ZURAMPIC full US Prescribing Information including LIMITATIONS OF USE and BOXED WARNING »
*** Click here for DUZALLO full US Prescribing Information including LIMITATIONS OF USE and BOXED WARNING »

 

For information about our clinical trials. please go to www.clinicaltrials.gov.

Scientific inquiries regarding Ironwood investigational medicines »
Investigator inquiries regarding Ironwood-sponsored clinical trials »
Investigator inquiries regarding investigator-initiated studies »
Patient inquiries regarding Ironwood-sponsored clinical trials »